TACSTD2 and breast carcinoma: Experiment shows that TACSTD2 expression is high in breast cancer cell lines, MCF-7 and MDA-MB-231 (Figure 7-B), and FI treatment enhances the expression of TACSTD2 (Figure 7-C and Additional file 1, Table S2).